CU20200062A7 - CYCLIC DINUCLEOTIDE CYCLOPENTANE INTERFERON GENES STIMULATOR COMPOUNDS - Google Patents

CYCLIC DINUCLEOTIDE CYCLOPENTANE INTERFERON GENES STIMULATOR COMPOUNDS

Info

Publication number
CU20200062A7
CU20200062A7 CU2020000062A CU20200062A CU20200062A7 CU 20200062 A7 CU20200062 A7 CU 20200062A7 CU 2020000062 A CU2020000062 A CU 2020000062A CU 20200062 A CU20200062 A CU 20200062A CU 20200062 A7 CU20200062 A7 CU 20200062A7
Authority
CU
Cuba
Prior art keywords
cyclopentane
cyclic dinucleotide
interferon genes
compounds
stimulator compounds
Prior art date
Application number
CU2020000062A
Other languages
Spanish (es)
Inventor
Andrew Fensome
Ketan S Gajiwala
Mehran Jalaie
Andreas Maderna
Indrawan James Mcalpine
Ryan Patman
Eugene Yuanjin Rui
Martin James Wythes
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Priority claimed from PCT/IB2019/052009 external-priority patent/WO2019175776A1/en
Publication of CU20200062A7 publication Critical patent/CU20200062A7/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

<p>La presente invención se refiere a Compuestos de la fórmula general (I):</p> <p>ESPACIO PARA FÓRMULA</p> <p>útiles en el tratamiento del crecimiento celular anormal en mamíferos, especialmente en humanos y como agentes anticancerígenos.</p><p> The present invention relates to Compounds of the general formula (I): </p> <p> SPACE FOR FORMULA </p> <p> useful in the treatment of abnormal cell growth in mammals, especially in humans and as anticancer agents. </p>

CU2020000062A 2018-03-15 2019-03-12 CYCLIC DINUCLEOTIDE CYCLOPENTANE INTERFERON GENES STIMULATOR COMPOUNDS CU20200062A7 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201862643467P 2018-03-15 2018-03-15
US201862666204P 2018-05-03 2018-05-03
US201862742532P 2018-10-08 2018-10-08
PCT/IB2019/052009 WO2019175776A1 (en) 2018-03-15 2019-03-12 Cyclopentane-based modulators of sting (stimulator of interferon genes)

Publications (1)

Publication Number Publication Date
CU20200062A7 true CU20200062A7 (en) 2021-04-07

Family

ID=75847974

Family Applications (1)

Application Number Title Priority Date Filing Date
CU2020000062A CU20200062A7 (en) 2018-03-15 2019-03-12 CYCLIC DINUCLEOTIDE CYCLOPENTANE INTERFERON GENES STIMULATOR COMPOUNDS

Country Status (1)

Country Link
CU (1) CU20200062A7 (en)

Similar Documents

Publication Publication Date Title
SA519401435B1 (en) cyclic dinucleotides
CU24408B1 (en) DIHYDROISOQUINOLINONA SUBSTITUTED COMPOUNDS
CO2019008783A2 (en) Cyclic dinucleotide compounds for the treatment of cancer
CO2020002961A2 (en) Pyruvate kinase activators for use in the treatment of blood disorders
CU24414B1 (en) LACTAMAS N- (REPLACED HETEROARILE) USEFUL FUSIONATES IN THE TREATMENT OF ABNORMAL CELL GROWTH
CU20170056A7 (en) METHODS TO TREAT INFECTIONS BY VIRUS FILOVIRIDAE
MX2020011254A (en) ANTI-BCMA T CAR CELLS FOR PLASMA CELL DEPLETION.
MX2020009413A (en) Car-cd30 t cells for treatment of cd30+ tumors.
UY35381A (en) PIRROLOTRIAZINAS AS INHIBITORS OF THE POTASSIUM ION CHANNEL
ECSP18012103A (en) COLONY STIMULATING FACTOR RECEPTOR 1 (CSF-1R) INHIBITORS
UY34750A (en) ? COMPOUNDS FOR HIV TREATMENT, COMPOSITIONS, PREPARATION METHODS, INTERMEDIARIES AND THERAPEUTIC METHODS ?.
CU24564B1 (en) 2-HETEROARYL-3-OXO-2,3-DIHYDROPYRIDAZINE-4-CARBOXAMIDES
MX383531B (en) Novel bacteriophage CLO-PEP-1 from Clostridium perfringens and its use to inhibit proliferation of Clostridium perfringens
UY33199A (en) 5-ALQUINIL-PYRIMIDINS.
CU24402B1 (en) 2.6 USED SUBSTITUTED PURINS IN THE TREATMENT OF PROLIFERATIVE DISORDERS SUCH AS CANCER
CU20200038A7 (en) COMPOUNDS DERIVED FROM PYRAZOLO-PIRROLO-PYRIMIDINE-DIONA AS INHIBITORS OF P2X3
PH12019501224A1 (en) Compositions for treatment of polycystic kidney disease
UY37932A (en) PROCESS TO PRODUCE HERBICIDE PIRIDAZINONE COMPOUNDS
CR20130094A (en) ADENOSINE A1 AGONISTS FOR THE TREATMENT OF GLAUCOMA AND EYE HYPERTENSION
CO2020001506A2 (en) New compounds
CU24420B1 (en) DERIVATIVES OF DIHETEROCICLO LINKED TO CYCLALKYL
CR20110023A (en) NIFURTIMOX FOR THE TREATMENT OF DISEASES CAUSED BY TRICHOMONADIDA
CU20200062A7 (en) CYCLIC DINUCLEOTIDE CYCLOPENTANE INTERFERON GENES STIMULATOR COMPOUNDS
UY37210A (en) PROCESS FOR THE PREPARATION OF PYRIDINYLIMIDAZOLONES
MX2024003499A (en) CYCLIC PEROXIDES AS PRODRUGS FOR SELECTIVE DELIVERY OF AGENT.